Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313892726> ?p ?o ?g. }
Showing items 1 to 95 of
95
with 100 items per page.
- W4313892726 endingPage "448" @default.
- W4313892726 startingPage "439" @default.
- W4313892726 abstract "Unfractionated heparin (UFH) and low molecular weight heparin (LMWH) are often administered to prevent venous thromboembolism (VTE) in critically ill patients. However, the preferred prophylactic agent (UFH or LMWH) is not known. We compared the all-cause mortality rate in patients receiving UFH to LMWH for VTE prophylaxis. We conducted a retrospective propensity score adjusted analysis of patients admitted to neuro-critical, surgical, or medical intensive care units. Patients were included if they were screened with venous duplex ultrasonography or computed tomography angiography for detection of VTE. The primary outcome was all-cause mortality. Secondary outcomes included the prevalence of VTE, deep vein thrombosis (DVT), pulmonary embolism (PE), and hospital length of stay (LOS). Initially 2228 patients in the cohort were included for analysis, 1836 (82%) patients received UFH, and 392 (18%) patients received enoxaparin. After propensity score matching, a well-balanced cohort of 618 patients remained in the study (309 patients receiving UFH; 309 patients receiving enoxaparin). The use of UFH for VTE prophylaxis in ICU patients was associated with similar rates of all-cause mortality compared with enoxaparin [RR 0.73; 95% CI 0.43–1.24, p = 0.310]. There were no differences in the prevalence of DVT, prevalence of PE or hospital LOS between the two groups, DVT [RR 0.93; 95% CI 0.56–1.53, p = 0.889], PE [RR 1.50; 95% CI 0.78–2.90, p = 0.296] and LOS [9 ± 9 days vs 9 ± 8; p = 0.857]. A trend toward mortality benefit was observed in NICU [RR 0.37; 95% CI 0.13–1.07, p = 0.062] and surgical patients [RR 0.43; 95% CI 0.17–1.02, p = 0.075] favoring the enoxaparin group. The use of UFH for VTE prophylaxis in ICU patients was associated with similar rates of VTE, all-cause mortality and LOS compared to enoxaparin. In subgroup analysis, neuro-critical and surgical patients who received UFH had a higher rate of mortality than those who received enoxaparin." @default.
- W4313892726 created "2023-01-10" @default.
- W4313892726 creator A5003850660 @default.
- W4313892726 creator A5014239985 @default.
- W4313892726 creator A5020338689 @default.
- W4313892726 creator A5055458864 @default.
- W4313892726 creator A5075005668 @default.
- W4313892726 creator A5075275684 @default.
- W4313892726 date "2023-01-10" @default.
- W4313892726 modified "2023-10-18" @default.
- W4313892726 title "Enoxaparin may be associated with lower rates of mortality than unfractionated heparin in neurocritical and surgical patients" @default.
- W4313892726 cites W1496337022 @default.
- W4313892726 cites W1840055524 @default.
- W4313892726 cites W1991799973 @default.
- W4313892726 cites W2022932023 @default.
- W4313892726 cites W2034909575 @default.
- W4313892726 cites W2038601100 @default.
- W4313892726 cites W2064642186 @default.
- W4313892726 cites W2081869416 @default.
- W4313892726 cites W2085354161 @default.
- W4313892726 cites W2110992040 @default.
- W4313892726 cites W2120103059 @default.
- W4313892726 cites W2121273150 @default.
- W4313892726 cites W2160704894 @default.
- W4313892726 cites W2321905524 @default.
- W4313892726 cites W2418821229 @default.
- W4313892726 cites W2606711329 @default.
- W4313892726 cites W2762985035 @default.
- W4313892726 cites W2902174064 @default.
- W4313892726 cites W3134386391 @default.
- W4313892726 cites W3195709555 @default.
- W4313892726 cites W4296149224 @default.
- W4313892726 cites W51196085 @default.
- W4313892726 doi "https://doi.org/10.1007/s11239-022-02755-w" @default.
- W4313892726 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36624202" @default.
- W4313892726 hasPublicationYear "2023" @default.
- W4313892726 type Work @default.
- W4313892726 citedByCount "1" @default.
- W4313892726 countsByYear W43138927262023 @default.
- W4313892726 crossrefType "journal-article" @default.
- W4313892726 hasAuthorship W4313892726A5003850660 @default.
- W4313892726 hasAuthorship W4313892726A5014239985 @default.
- W4313892726 hasAuthorship W4313892726A5020338689 @default.
- W4313892726 hasAuthorship W4313892726A5055458864 @default.
- W4313892726 hasAuthorship W4313892726A5075005668 @default.
- W4313892726 hasAuthorship W4313892726A5075275684 @default.
- W4313892726 hasBestOaLocation W43138927261 @default.
- W4313892726 hasConcept C126322002 @default.
- W4313892726 hasConcept C141071460 @default.
- W4313892726 hasConcept C167135981 @default.
- W4313892726 hasConcept C17923572 @default.
- W4313892726 hasConcept C179755657 @default.
- W4313892726 hasConcept C2776265017 @default.
- W4313892726 hasConcept C2776884760 @default.
- W4313892726 hasConcept C2777557582 @default.
- W4313892726 hasConcept C2778959117 @default.
- W4313892726 hasConcept C2780011451 @default.
- W4313892726 hasConcept C2780868729 @default.
- W4313892726 hasConcept C71924100 @default.
- W4313892726 hasConceptScore W4313892726C126322002 @default.
- W4313892726 hasConceptScore W4313892726C141071460 @default.
- W4313892726 hasConceptScore W4313892726C167135981 @default.
- W4313892726 hasConceptScore W4313892726C17923572 @default.
- W4313892726 hasConceptScore W4313892726C179755657 @default.
- W4313892726 hasConceptScore W4313892726C2776265017 @default.
- W4313892726 hasConceptScore W4313892726C2776884760 @default.
- W4313892726 hasConceptScore W4313892726C2777557582 @default.
- W4313892726 hasConceptScore W4313892726C2778959117 @default.
- W4313892726 hasConceptScore W4313892726C2780011451 @default.
- W4313892726 hasConceptScore W4313892726C2780868729 @default.
- W4313892726 hasConceptScore W4313892726C71924100 @default.
- W4313892726 hasFunder F4320308129 @default.
- W4313892726 hasFunder F4320337472 @default.
- W4313892726 hasIssue "3" @default.
- W4313892726 hasLocation W43138927261 @default.
- W4313892726 hasLocation W43138927262 @default.
- W4313892726 hasLocation W43138927263 @default.
- W4313892726 hasOpenAccess W4313892726 @default.
- W4313892726 hasPrimaryLocation W43138927261 @default.
- W4313892726 hasRelatedWork W1509199054 @default.
- W4313892726 hasRelatedWork W1965732988 @default.
- W4313892726 hasRelatedWork W1990111999 @default.
- W4313892726 hasRelatedWork W2033815732 @default.
- W4313892726 hasRelatedWork W2075890389 @default.
- W4313892726 hasRelatedWork W220073818 @default.
- W4313892726 hasRelatedWork W2407594508 @default.
- W4313892726 hasRelatedWork W2414818497 @default.
- W4313892726 hasRelatedWork W2432913978 @default.
- W4313892726 hasRelatedWork W2981730791 @default.
- W4313892726 hasVolume "55" @default.
- W4313892726 isParatext "false" @default.
- W4313892726 isRetracted "false" @default.
- W4313892726 workType "article" @default.